Clinical trials: Insulin Pump
Diabetes Technology, Continuous Glucose Monitoring System
Healthcare Practitioners Knowledge on Diabetes Technology
Assessment of knowledge of healthcare professionals of diabetes mellitus technology (continuous glucose monitoring systems and insulin pump therapy).
- Conditions
- Diabetes Technology, Continuous Glucose Monitoring System, Continuous Insulin Infusion System, Insulin Pump Therapy
- Trial name
- NCT07822945
- Testing
- Questionnaire assessing knowledge on diabetes technology
- Where
- Greece
- Volunteers
- 112 people, healthy volunteers welcome
- Sponsor
- Aristotle University Of Thessaloniki
Type 1 Diabetes Mellitus, Insulin Pump
Evaluating an Insulin Pump for Time in Range (TIR) in Patients with Type 1 Diabetes
Diabetes mellitus is a metabolic disorder caused by genetic, environmental changes, mental health issues, immune disorders, and other factors.
- Conditions
- Type 1 Diabetes Mellitus, Insulin Pump, Time in Range
- Trial name
- NCT06741943
- Testing
- insulin pump (model: AR-B200A)
- Where
- China
- Volunteers
- 60 people
- Sponsor
- Tao Yuan，MD
Insulin Pump Therapy
Closed Loop Pumps vs. Traditional Open Loop Pumps in Managing Blood Glucose Levels in T1DM Patients Fasting in Ramadan.
Our proposed study aims to build upon the existing findings by conducting a first-of-its-kind randomized controlled trial (RCT) that directly compares Advanced Hybrid Closed Loop (AHCL) and open-loop insulin delivery (OLID)…
- Trial name
- HybridRam (NCT06416202)
- Testing
- Advanced hybrid closed loop insulin pump, Open Loop Insulin Delivery system
- Where
- Saudi Arabia
- Volunteers
- 75 people
- Sponsor
- King Fahad Medical City
Insulin Pump，Continuous Glucose Monitoring Technology
The Effect of Short-term Insulin Intensive Therapy Based on the Application of Insulin Pump and Real-time Dynamic Glucose Monitoring Technology on Reversing the Newly Diagnosed Type 2 Diabetes
This study aims to explore the effectiveness and safety of the in-hospital-out-of-hospital synergistic short-term insulin intensive therapy model based on patch insulin pump and continuous glucose monitoring technology through a…
- Trial name
- NCT06127433
- Testing
- Insulin Glargine, Metformin, Dapagliflozin
- Where
- China
- Volunteers
- 210 people
- Sponsor
- Sun Yat-sen University
Type 1 Diabetes, Insulin Pump Therapy
Impact of Hybrid Closed Loop Systems in People With Type I Diabetes
Type 1 diabetes requires people with type 1 diabetes to constantly monitor their blood glucose and adjust their insulin doses to try and keep glucose levels in range.
- Conditions
- Type 1 Diabetes, Insulin Pump Therapy, Patient Reported Outcomes
- Trial name
- ProHCL (NCT05348499)
- Testing
- Questionnaire/Interview
- Where
- United Kingdom
- Volunteers
- 350 people
- Sponsor
- University of Leicester
Type 1 Diabetes, Basal-bolus Multiple-dily Insulin Injections
Self-management of Type 1 Diabetes Under Functional Insulin Therapy
Therapeutic education of patients is a mandatory component of intensive insulin therapy of type 1 diabetes in order to reach optimal safety and efficacy.
- Conditions
- Type 1 Diabetes, Basal-bolus Multiple-dily Insulin Injections, Insulin Pump (CSII)
- Trial name
- EVAUTODIAB (NCT02272348)
- Testing
- Training course to functional insulin therapy, Usual diabetes management.
- Where
- France
- Volunteers
- 13 people
- Sponsor
- University Hospital, Montpellier
T1DM, Health Related Quality of Life
Health-related Quality of Life and Psychosocial Aspects of Diabetes Technology (Insulin Pumps)
This study will be prospective comparative trial comparing between insulin pumps vs Multiple daily injections (MDI) in treatment of type 1 diabetes mellitus (T1DM) in terms of health- related quality of life (HRQL) and efficacy…
- Conditions
- T1DM, Health Related Quality of Life, Insulin Pump
- Trial name
- NCT04756011
- Testing
- Health related quality of life
- Where
- Egypt
- Volunteers
- 60 people
- Sponsor
- Ain Shams University
Insulin Pump Therapy in Treating Diabetic Nephropathy
Effect Insulin Pump Therapy to Patients With Diabetic Nephropathy
The recent study suggested that oxidative stress resulting from increased production of reactive oxygen species (ROS) plays a crucial role in the development of diabetic complications.
- Trial name
- NCT03174821
- Testing
- Insulin pump
- Volunteers
- 160 people, healthy volunteers welcome
- Sponsor
- Chinese PLA General Hospital
Type 1 Diabetes, Insulin Pump Therapy
MD Logic Pump Advisor- Adults Study
Prospective, randomized, controlled, 30-78 days trial comparing MD-Logic pump algorithm to the standard of care of patients with type 1 diabetes.
- Trial name
- NCT01157923
- Testing
- MD Logic Pump Advisor
- Where
- 2 sites in Israel, Slovenia
- Volunteers
- 18 people
- Sponsor
- Rabin Medical Center
Diabetes Mellitus, Type 1 Diabetes
Tandem Predictive Low Glucose Suspend Inpatient Feasibility Study
The goal of this study is to assess the functionality of an integrated predictive low glucose suspend system designed to minimize the incidence and duration of hypoglycemia by suspending insulin delivery if hypoglycemia is…
- Conditions
- Diabetes Mellitus, Type 1 Diabetes, Insulin Pump
- Trial name
- NCT02877771
- Testing
- t:slim insulin pump with predictive low glucose suspend
- Where
- 2 sites in United States
- Volunteers
- 10 people
- Sponsor
- Tandem Diabetes Care, Inc.
Type 1 Diabetes Mellitus, Treatement by Insulin Pump
Hybrid Artificial Pancreas in Home Setting
The primary purpose of this study is the evaluate an Artificial Pancreas during 2 months in home setting in Type 1 Diabetic patients
- Trial name
- AP Hybrid (NCT02153190)
- Testing
- HYBRID, OPEN
- Where
- 3 sites in France, Italy and 1 more
- Volunteers
- 36 people
- Sponsor
- University Hospital, Montpellier
Type 1 Diabetes With a Subcutaneous Insulin Pump, Adjustment of the Recommended Basal Insulin Flow Rate in the Event of Physical Activity
Validation of Algorithms for Basal Insulin Rate Reductions in Type 1 Diabetic Patients Practising Physical Activity
Primary aim: To show that in subjects with type 1 diabetes with a subcutaneous continuous insulin infusion, adjustment of the recommended basal insulin flow rate in the event of physical activity allows the subjects to practice…
- Conditions
- Type 1 Diabetes With a Subcutaneous Insulin Pump, Adjustment of the Recommended Basal Insulin Flow Rate in the Event of Physical Activity, Adjustment of the Recommended Prandial Insulin in the Event of Physical Activity
- Trial name
- DIABRASPORT (NCT01277965)
- Testing
- 50%VO2maxTBR50, 50%VO2max TBR80, 75%VO2max TBR80
- Where
- France
- Volunteers
- 20 people
- Sponsor
- Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
Type 1 Diabetes, Insulin Pump Users
Feasibility Study of the Solo™ Insulin Pump
The purpose of this study is to assess the safety and usability of the Solo™ insulin MicroPump in subjects with type 1 diabetes who are pump users.
- Trial name
- NCT01055951
- Testing
- Solo MicroPump
- Where
- 3 sites in Austria, Israel
- Volunteers
- 90 people
- Sponsor
- Medingo Ltd
Diabetes Mellitus, Type 1, Insulin Pump, Programmable
Carbohydrate Counting in Adults With Type 1 Diabetes Treated With Continuous Subcutaneous Insulin Infusion
The investigators postulate that carbohydrate (CHO) counting in adult patients with type 1 diabetes mellitus (T1DM) treated with continuous subcutaneous insulin infusion (CSII) may improve glycemic control, glycemic variability…
- Trial name
- GIOCAR (NCT01173991)
- Testing
- Carbohydrate counting training
- Where
- Italy
- Volunteers
- 61 people
- Sponsor
- IRCCS San Raffaele